Evidence map›Paper›PMID 29163819›Full record

ArticleOncotarget2017

Exploring the model of PC12 apoptosis induced by OGSD/R through

Yanqing Sun, Wei Zhu, Shengyuan Zhou, Zhiwei Wang, Xiongsheng Chen, Lianshun Jia

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yanqing SunDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Wei ZhuDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Shengyuan ZhouDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Zhiwei WangDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Xiongsheng ChenDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Lianshun JiaDepartment of Spine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China.
Second Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo explicit cell apoptosis trend in PC12 oxygen-glucose-serum deprivation/restoration (OGSD/R) model and provide experimental bases for neural cell simulation in ischemia reperfusion injury

methodsOGSD/R model was constructed using the passage PC12 cells

resultsPC12 apoptosis was induced by OGSD and aggravated after restoration. CCK8 assay indicated that cell activity reached minimum after 1h of oxygen-glucose-serum restoration (OGR). DAPI staining suggested that apoptosis was the most serious after 1h of OGR, causing apoptotic cell nucleus pyknosis, particle spot formation, and fracture of cells with serious apoptosis forming pieces, and nucleus disintegration. The percentage of apoptotic cells exhibited increased trend after restoration, and reached the highest at 1h of OGR. Moreover, the expression of procaspase-3 and caspase-12 were extremely enhanced after OGD, especially 1h after OGR.

conclusionsPC12 apoptosis is induced by OGSD and aggravated after restoration. The apoptosis of PC12 reaches the highest at 1h after OGR, which may provide experimental bases for spinal cord ischemia reperfusion injury treatment.

Indexed as

apoptosisischemia reperfusionoxygen-glucose-serum deprivation/restorationPC12

Identifiers

PMID29163819
PMCPMC5685740
OpenAlexW2762107040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.